文献速递创伤与烧伤重症综合管理与镇静镇痛

创伤幸存者中心:弥合创伤中心出院后照护的巨大未满足需求

The Center for Trauma Survivorship: Addressing the great unmet need for posttrauma center care.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论多学科创伤幸存者中心(CTS)可提高创伤患者出院后随访依从性并提供行为健康服务,似乎能减少出院后1年内的急诊就诊。

创伤中心出院后门诊随访率低于30%,创伤后应激障碍和抑郁常见但极少获得行为健康服务。本研究通过焦点小组了解创伤幸存者出院后问题,设立多学科创伤幸存者中心(CTS),纳入18至80岁、ICU停留超过2天或新损伤严重度评分≥16分的患者,由专职导航员安排包含躯体与行为健康照护的随访,筛查阳性者转介行为健康服务,并提供24/7团队访问。1年内107例患者共386次CTS访视,失约率17%,筛查阳性者中86%成功获得行为健康服务;出院后急诊利用率显著低于CTS成立前1年相似损伤组。作者认为CTS填补了创伤中心出院后照护的巨大缺口,创伤照护必须在患者离开创伤中心后长期继续。

要点

  • 创伤中心出院后门诊随访率低于30%,创伤后应激障碍和抑郁常见但极少获得必要行为健康服务。
  • CTS纳入18至80岁、ICU停留超过2天或新损伤严重度评分≥16分的创伤患者,由专职导航员安排随访。
  • 1年内107例患者共386次CTS访视,每次预约平均超过1小时,CTS失约率为17%。
  • 筛查创伤后应激障碍/抑郁阳性的患者中86%成功获得行为健康服务。
  • 出院后急诊利用率显著低于CTS成立前1年相似损伤组,出院后急诊和住院最常见原因为感染或无关疾病。

适用人群与场景

  • 创伤中心出院患者,年龄18至80岁,且ICU停留超过2天或新损伤严重度评分≥16分。
  • 急诊/ICU场景:创伤中心出院后随访阶段。

诊断标准与关键阈值

  • 纳入标准:年龄18至80岁,且ICU停留超过2天或新损伤严重度评分≥16分。
  • 对患者进行创伤后应激障碍和抑郁筛查,筛查阳性者转介行为健康服务。

处置流程与药物剂量

  • CTS访视由专职导航员安排,包含躯体健康和行为健康照护。
  • 对患者筛查创伤后应激障碍和抑郁,筛查阳性者转介行为健康服务。
  • 为患者提供24/7访问CTS团队的途径。

研究设计与关键结果

  • 研究类型:质量改进项目(设立CTS),纳入107例患者,1年内共386次CTS访视。
  • 每次预约平均时间超过1小时,CTS失约率为17%。
  • 筛查创伤后应激障碍/抑郁阳性的患者中86%成功获得行为健康服务。
  • 出院后急诊和住院最常见原因为感染或无关疾病。
  • 出院后急诊利用率显著低于CTS成立前1年相似损伤组。
  • 焦点小组显示患者普遍感到出院后被创伤中心遗弃。

证据类型、等级与局限

  • 证据类型:质量改进项目,证据等级为治疗性III级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为CTS填补了创伤中心出院后照护的巨大缺口,提高预约依从性并提供躯体与行为健康服务。
  • 作者认为CTS似乎能减少出院后1年内的急诊就诊。
  • 作者认为为实现最佳长期康复,创伤照护必须在患者离开创伤中心后长期继续。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Returning patients to preinjury status is the goal of a trauma system. Trauma centers (TCs) provide inpatient care, but postdischarge treatment is fragmented with clinic follow-up rates of <30%. Posttraumatic stress disorder (PTSD) and depression are common, but few patients ever obtain necessary behavioral health services. We postulated that a multidisciplinary Center for Trauma Survivorship (CTS) providing comprehensive care would meet patient's needs, improve postdischarge compliance, deliver behavioral health, and decrease unplanned emergency department (ED) visits and readmissions.

METHODS: Focus groups of trauma survivors were conducted to identify issues following TC discharge. Center for Trauma Survivorship eligible patients are aged 18 to 80 years and have intensive care unit stay of >2 days or have a New Injury Severity Score of ≥16. Center for Trauma Survivorship visits were scheduled by a dedicated navigator and included physical and behavioral health care. Patients were screened for PTSD and depression. Patients screening positive were referred for behavioral health services. Patients were provided 24/7 access to the CTS team. Outcomes include compliance with appointments, mental health visits, unplanned ED visits, and readmissions in the year following discharge from the TC.

RESULTS: Patients universally felt abandoned by the TC after discharge. Over 1 year, 107 patients had 386 CTS visits. Average time for each appointment was >1 hour. Center for Trauma Survivorship "no show" rate was 17%. Eighty-six percent screening positive for PTSD/depression successfully received behavioral health services. Postdischarge ED and hospital admissions were most often for infections or unrelated conditions. Emergency department utilization was significantly lower than a similarly injured group of patients 1 year before the inception of the CTS.

CONCLUSION: A CTS fills the vast gaps in care following TC discharge leading to improved compliance with appointments and delivery of physical and behavioral health services. Center for Trauma Survivorship also appears to decrease ED visits in the year following discharge. To achieve optimal long-term recovery from injury, trauma care must continue long after patients leave the TC.

LEVEL OF EVIDENCE: Therapeutic, Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Livingston DH, La Bagnara S, Sieck D, et al. The Center for Trauma Survivorship: Addressing the great unmet need for posttrauma center care. J Trauma Acute Care Surg. 2020. PMID: 32345893. doi:10.1097/TA.0000000000002775

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。